Traditional pacemakers have long been a vital treatment for individuals with slow heart rhythms (bradycardia). However, they come with challenges, including the need for leads (wires) and recovery from surgical incisions.
In November 2024, Dr Jeremy Chow and Dr Pipin Kojodjojo, Cardiac Electrophysiologists from Asian Heart & Vascular Centre successfully implanted the AVEIR leadless pacemaker for patients at Mount Elizabeth Hospital and Mount Elizabeth Novena Hospital.
Unlike conventional pacemakers, such leadless pacemakers eliminate the need for wires and surgical cuts, resulting in lower risk of complications.
“For decades, we’ve depended on pacemakers with leads to treat slow heart rhythms, but they have their own set of challenges. The AVEIR leadless pacemaker now provides a minimally invasive alternative that may provide longer-term outcomes,” shared Dr Chow.
Dr Kojodjojo added, “This advancement brings us closer to a future where pacemaker implants are simpler and durable. With the ability to synchronise both upper and lower heart chambers, easy retrieval for battery replacement, and an extended battery lifespan of up to 30 years for some patients, it presents another option for patients needing pacemakers.”
Since the first successful procedure, six more patients have received the leadless pacemaker at our IHH Healthcare Singapore hospitals - all without complications.
With a strong commitment to clinical excellence and patient experience, IHH continuously seeks innovative solutions to enhance patient care and elevate quality of life.
Related Stories
Project Renaissance at Mount Elizabeth Hospital, Where Legacy Meets the Future of Care
Over a span of 1,095 days, Project Renaissance marked a significant chapter in the evolution of Mount Elizabeth Hospital, one of Singapore’s most established private healthcare institutions. Conceived as a strategic transformation rather than a conventional refurbishment, the initiative sought to position the hospital for the demands of a rapidly changing healthcare landscape.
IHH Healthcare North Asia Strengthens Integrated Care Through Strategic Partnership
IHH Malaysia Partners Libyan Government for Medical Referrals
IHH Healthcare Malaysia signed a Memorandum of Understanding (MOU) with The Government of Libya on 9 February, establishing a structured medical referral pathway for Libyan civil servants requiring specialist treatment at 18 hospitals across IHH’s Malaysian network.
Agilus Diagnostics Expands Access to Next-Generation Precision Genomics
Agilus Diagnostics, a subsidiary of Fortis Healthcare, has installed the Illumina NovaSeq X sequencing platform at its Mumbai reference laboratory, marking a major step forward for precision genomics in India.
Parkway Shanghai Opens International Centre for Hepatobiliary and Pancreatic Diseases
